These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
209 related articles for article (PubMed ID: 29532745)
1. Association of smoking but not HLA-DRB1*15:01, APOE or body mass index with brain atrophy in early multiple sclerosis. Graetz C; Gröger A; Luessi F; Salmen A; Zöller D; Schultz J; Siller N; Fleischer V; Bellenberg B; Berthele A; Biberacher V; Havla J; Hecker M; Hohlfeld R; Infante-Duarte C; Kirschke JS; Kümpfel T; Linker R; Paul F; Pfeuffer S; Sämann P; Toenges G; Weber F; Zettl UK; Jahn-Eimermacher A; Antony G; Groppa S; Wiendl H; Hemmer B; Mühlau M; Lukas C; Gold R; Lill CM; Zipp F Mult Scler; 2019 Apr; 25(5):661-668. PubMed ID: 29532745 [TBL] [Abstract][Full Text] [Related]
2. HLA-DRB1*1501, -DQB1*0301, -DQB1*0302, -DQB1*0602, and -DQB1*0603 alleles are associated with more severe disease outcome on MRI in patients with multiple sclerosis. Zivadinov R; Uxa L; Bratina A; Bosco A; Srinivasaraghavan B; Minagar A; Ukmar M; Benedetto Sy; Zorzon M Int Rev Neurobiol; 2007; 79():521-35. PubMed ID: 17531857 [TBL] [Abstract][Full Text] [Related]
4. Latitude and HLA-DRB1*04:05 independently influence disease severity in Japanese multiple sclerosis: a cross-sectional study. Nakamura Y; Matsushita T; Sato S; Niino M; Fukazawa T; Yoshimura S; Hisahara S; Isobe N; Shimohama S; Watanabe M; Yoshida K; Houzen H; Miyazaki Y; Yamasaki R; Kikuchi S; Kira J; J Neuroinflammation; 2016 Sep; 13(1):239. PubMed ID: 27599848 [TBL] [Abstract][Full Text] [Related]
5. The association of HLA-DRB1 and HLA-DQB1 alleles with genetic susceptibility to multiple sclerosis in the Slovak population. Michalik J; Čierny D; Kantorová E; Kantárová D; Juraj J; Párnická Z; Kurča E; Dobrota D; Lehotský J Neurol Res; 2015; 37(12):1060-7. PubMed ID: 26744784 [TBL] [Abstract][Full Text] [Related]
6. Multiple sclerosis and HLA genotypes: A possible influence on brain atrophy. Lorefice L; Fenu G; Sardu C; Frau J; Coghe G; Costa G; Schirru L; Secci MA; Sechi V; Barracciu MA; Marrosu MG; Cocco E Mult Scler; 2019 Jan; 25(1):23-30. PubMed ID: 29111883 [TBL] [Abstract][Full Text] [Related]
7. HLA-DRB*1501 associations with magnetic resonance imaging measures of grey matter pathology in multiple sclerosis. Yaldizli Ö; Sethi V; Pardini M; Tur C; Mok KY; Muhlert N; Liu Z; Samson RS; Wheeler-Kingshott CA; Yousry TA; Houlden H; Hardy J; Miller DH; Chard DT Mult Scler Relat Disord; 2016 May; 7():47-52. PubMed ID: 27237756 [TBL] [Abstract][Full Text] [Related]
8. HLA (A-B-C and -DRB1) alleles and brain MRI changes in multiple sclerosis: a longitudinal study. Liguori M; Healy BC; Glanz BI; Khoury SJ; Moscufo N; Weiner HL; De Jager PL; Guttmann CR Genes Immun; 2011 Apr; 12(3):183-90. PubMed ID: 21179117 [TBL] [Abstract][Full Text] [Related]
9. Multiple sclerosis risk genotypes correlate with an elevated cerebrospinal fluid level of the suggested prognostic marker CXCL13. Lindén M; Khademi M; Lima Bomfim I; Piehl F; Jagodic M; Kockum I; Olsson T Mult Scler; 2013 Jun; 19(7):863-70. PubMed ID: 23175382 [TBL] [Abstract][Full Text] [Related]
10. Apolipoprotein genotype does not influence MS severity, cognition, or brain atrophy. van der Walt A; Stankovich J; Bahlo M; Taylor BV; van der Mei IA; Foote SJ; Kilpatrick TJ; Rubio JP; Butzkueven H Neurology; 2009 Sep; 73(13):1018-25. PubMed ID: 19786693 [TBL] [Abstract][Full Text] [Related]
11. The influence of combined genotypes of the HLADRB1*1501 and CD24 single nucleotide polymorphism on disease severity of Iranian multiple sclerosis patients. Ghlichnia HA; Kollaee A; Gaffarpoor M; Movafagh A; Ghlichnia B; Zamani M Acta Med Iran; 2014; 52(6):418-23. PubMed ID: 25130147 [TBL] [Abstract][Full Text] [Related]
12. The tag SNP for HLA-DRB1*1501, rs3135388, is significantly associated with multiple sclerosis susceptibility: cost-effective high-throughput detection by real-time PCR. Zivković M; Stanković A; Dincić E; Popović M; Popović S; Raicević R; Alavantić D Clin Chim Acta; 2009 Aug; 406(1-2):27-30. PubMed ID: 19433080 [TBL] [Abstract][Full Text] [Related]
14. Multiple Sclerosis Onset before and after COVID-19 Vaccination: Can HLA Haplotype Be Determinant? Bianco A; Di Sante G; Colò F; De Arcangelis V; Cicia A; Del Giacomo P; De Bonis M; Morganti TG; Carlomagno V; Lucchini M; Minucci A; Calabresi P; Mirabella M Int J Mol Sci; 2024 Apr; 25(8):. PubMed ID: 38674141 [TBL] [Abstract][Full Text] [Related]
15. Risk HLA-DRB1 alleles differentially influence brain and lesion volumes in Japanese patients with multiple sclerosis. Fukumoto S; Nakamura Y; Watanabe M; Isobe N; Matsushita T; Sakoda A; Hiwatashi A; Shinoda K; Yamasaki R; Tsujino A; Kira JI J Neurol Sci; 2020 Jun; 413():116768. PubMed ID: 32247967 [TBL] [Abstract][Full Text] [Related]
16. No major association of ApoE genotype with disease characteristics and MRI findings in multiple sclerosis. Zwemmer JN; van Veen T; van Winsen L; van Kamp GJ; Barkhof F; Polman CH; Uitdehaag BM Mult Scler; 2004 Jun; 10(3):272-7. PubMed ID: 15222690 [TBL] [Abstract][Full Text] [Related]
17. Relationship between HLA-DRB1* 11/15 genotype and susceptibility to multiple sclerosis in Iran. Abolfazli R; Samadzadeh S; Sabokbar T; Siroos B; Armaki SA; Aslanbeiki B; Ghelman M; Taheri T; Shakoori A J Neurol Sci; 2014 Oct; 345(1-2):92-6. PubMed ID: 25064442 [TBL] [Abstract][Full Text] [Related]
18. Associations of HLA DRB1 alleles with IgG oligoclonal bands and their influence on multiple sclerosis course and disability status. Balnytė R; Rastenytė D; Vaitkus A; Skrodenienė E; Vitkauskienė A; Ulozienė I Medicina (Kaunas); 2016; 52(4):217-222. PubMed ID: 27515835 [TBL] [Abstract][Full Text] [Related]
19. Analysis of ICAM1 gene polymorphism in Slovak multiple sclerosis patients. Shawkatová I; Javor J; Párnická Z; Bucová M; Čopíková-Cudráková D; Michalík J; Gmitterová K; Čierny D; Buc M; Ďurmanová V Folia Microbiol (Praha); 2017 Jul; 62(4):287-293. PubMed ID: 28130760 [TBL] [Abstract][Full Text] [Related]
20. Association of apolipoprotein E gene polymorphisms with blood lipids and their interaction with dietary factors. Shatwan IM; Winther KH; Ellahi B; Elwood P; Ben-Shlomo Y; Givens I; Rayman MP; Lovegrove JA; Vimaleswaran KS Lipids Health Dis; 2018 Apr; 17(1):98. PubMed ID: 29712557 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]